Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for SNDL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 2.64M
March 31, 2026 2.538M
December 31, 2025 18.00M
September 30, 2025 23.44M
June 30, 2025 6.851M
March 31, 2025 5.929M
December 31, 2024 15.07M
September 30, 2024 82.54M
June 30, 2024 3.401M
March 31, 2024 2.448M
December 31, 2023 10.22M
September 30, 2023 20.48M
June 30, 2023 -6.829M
March 31, 2023 -36.08M
December 31, 2022 22.10M
Date Value
September 30, 2022 7.332M
June 30, 2022 -13.83M
March 31, 2022 -20.54M
December 31, 2021 4.176M
September 30, 2021 -42.48M
June 30, 2021 -74.51M
March 31, 2021 -10.81M
December 31, 2020 -10.16M
September 30, 2020 -15.77M
June 30, 2020 -8.176M
March 31, 2020 -9.997M
December 31, 2019 -42.35M
September 30, 2019 -21.78M
June 30, 2019 -7.133M
March 31, 2019 -14.14M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
CannaPharmaRx, Inc. -0.1274M
Bakhu Holdings Corp. --
SpeakEasy Cannabis Club Ltd. --
Tilray Brands, Inc. -37.47M
Clearmind Medicine, Inc. -1.792M